Key Quantitative Figures

  • Potential revenue loss: ₹0.75 lakhs
  • Suspension duration: 5 days

Dates of Action

  • Order received on: July 4, 2026
  • Disclosure date: July 5, 2026

Parties Involved

  • Issuing authority: Asst. Commissioner & Licensing authority, Food & Drug Administrations, Nashik Maharashtra
  • Affected entity: Optival Health Solutions Private Limited (subsidiary of MedPlus Health Services Limited)
  • Store location: Samta Nagar Nashik Maharashtra

Nature of Violation

Alleged violations under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945

Financial Impact

Potential revenue loss quantified at ₹0.75 lakhs due to the 5-day suspension period

Disclosure Requirements

The information will be available on the company website (www.medplusindia.com) and stock exchange websites (www.bseindia.com and www.nseindia.com)